The Effect Pomegranate Seed Oil Prevention and Progression Pressure Ulcers in Intensive Care Patients

Launched by TC ERCIYES UNIVERSITY · Nov 29, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the effects of pomegranate seed oil on preventing and treating pressure ulcers, which are painful sores that can develop in patients who are bedridden or in intensive care for long periods. Pressure ulcers are a serious concern, particularly in intensive care units, where they can affect a patient’s recovery and lead to higher healthcare costs. The goal of this trial is to see if applying pomegranate seed oil on the skin can help reduce the risk of these sores developing or worsening.

To participate in this study, patients must meet certain criteria. They should be admitted to the intensive care unit within the first 24 hours, have a moderate to very high risk of developing pressure ulcers, and be expected to stay in intensive care for at least six days. Participants will not have any existing skin diseases or pressure sores, and they must meet specific health measures, such as having a certain level of hemoglobin in their blood. The study aims to provide insight into a natural treatment option that may help improve patient care and comfort in intensive care settings.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Without skin disease
• • Those within the first 24 hours of admission to the intensive care clinic,
• • Those with medium, high and very high risk according to the Braden risk assessment scale
• • Patients without malnutrition according to CONUT score
• • Those with hemoglobin level of 8 and above
• • Patients who will stay in intensive care for 6 days or more
• • Those with a BMI of 35 and below
• • Those whose oxygen saturation is 90 and above
• Exclusion Criteria:
• • Those who do not allow themselves or their first degree relatives to participate in the study,
• • Those with pressure sores during hospitalization,
• • Those with severe edema (+4 and above),
• • Those with albumin 2 and below
• • Those with prealbumin 10 and below,
• • Those who have a known allergy to any skin care product,
• • Patients with contraindications due to brain death, cardiac arrest, etc.